Logo image
Posterior circulation perforator aneurysms: A proposed management algorithm
Journal article

Posterior circulation perforator aneurysms: A proposed management algorithm

Thomas J Buell, Dale Ding, Daniel M S Raper, Ching-Jen Chen, Harry R Hixson, R. Webster Crowley, Avery J Evans, Mary E Jensen and Kenneth C Liu
Journal of NeuroInterventional Surgery, Vol.10(1)
2018

Abstract

Aged Algorithms Aneurysm, Ruptured Cerebral Angiography Disease Management Embolization, Therapeutic Female Follow-Up Studies Humans Intracranial Aneurysm Male Middle Aged Retrospective Studies Treatment Outcome aminocaproic acid antifibrinolytic agent tranexamic acid adult aged Article clinical article clinical outcome coil embolization computed tomographic angiography conservative treatment conventional angiography demography female follow up human intracranial aneurysm male posterior circulation perforator aneurysm priority journal Rankin scale retrospective study subarachnoid hemorrhage telephone interview algorithm aneurysm rupture artificial embolization brain angiography diagnostic imaging disease management intracranial aneurysm middle aged procedures treatment outcome
Introduction Subarachnoid hemorrhage (SAH) from posterior circulation perforator aneurysms (PCPAs) is rare and its natural history is unknown. Diagnosis may be difficult, acute management is poorly defined, and long-term recurrent SAH rates and clinical outcome data are lacking. Methods We searched our institution’s records for cases of PCPA rupture and analyzed patient demographics, Hunt and Hess (HH) grades, diagnostic imaging, management, and clinical outcomes. We conducted telephone interviews to calculate modified Rankin Scale (mRS) scores. Results We identified 9 patients (6 male, 3 female) with a ruptured PCPA who presented to the University of Virginia Health System (Charlottesville, VA, USA) between 2010 and 2016. Median and mean ages were 62 and 63 years, respectively. Median HH grade was 3. Seven of nine (78%) PCPAs were angiographically occult on initial imaging and median time to diagnosis was 5 days. Three conservatively managed patients had a mean mRS score of 0.67 (range 0–1) at mean follow-up of 35.3 months. Antifibrinolytic therapy was administered to all conservatively managed patients without thrombotic complication. Six patients receiving endovascular treatment had a mean mRS score of 2.67 (range 0–6) at mean follow-up of 49.2 months. No cases of recurrent SAH were seen in the study. Conclusions The rarity of PCPA has precluded long-term clinical follow-up until now. Our experience suggests low recurrent SAH rates. Until further studies are performed, conservative management, possibly combined with antifibrinolytic therapy, may be a viable treatment with acceptable long-term outcome.

Metrics

3 Record Views

Details

Logo image